On May 11, 2021 Imvax, a clinical stage immuno-oncology company driven to transform patient treatment and outcomes with its novel technology platform, reported that John Furey, chief executive officer, will present at the UBS Global Healthcare Virtual Conference at 1 p.m. EDT Wednesday, May 26, 2021 (Press release, Imvax, MAY 11, 2021, View Source [SID1234579725]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Furey, Dr. David Andrews, chief medical officer, and Dr. Mark Exley, chief scientific officer, will also participate in one-on-one investor meetings during the conference.

The presentation will be webcast live and will be available for replay for 30 days following the event at https://bit.ly/3gPPF8U.